Cui bono? Is Australia taking a step to managed healthcare as in the United States?

Jeffrey C. L. Looi, Stephen Allison, William Pring, Stephen R. Kisely, Tarun Bastiampillai

Research output: Contribution to journalComment/debate

4 Citations (Scopus)


The Australian Competition and Consumer Commission (ACCC, 2021) is an independent statutory body that oversees competition and fair trading. It is currently reviewing an application by Honeysuckle Health (HH) and NIB to form and operate a buying-group to negotiate and manage contracts with healthcare providers on behalf of private health insurers (PHIs). HH is a joint venture of Australian health insurer NIB and Cigna Corporation, a global health services company based in the United States. Individual practitioners and healthcare providers have registered their concerns with the ACCC about the possible effects on choice and autonomy for patients and healthcare providers. The ACCC has released a draft determination that is broadly supportive of the proposal based on the balance of risks and benefits. We discuss the policy implications for patients and private psychiatrists in Australia.
Original languageEnglish
Pages (from-to)211-213
Number of pages3
JournalAustralian and New Zealand Journal of Psychiatry
Issue number3
Early online date18 Aug 2021
Publication statusPublished - Mar 2022


  • healthcare
  • private health insurers
  • global health services


Dive into the research topics of 'Cui bono? Is Australia taking a step to managed healthcare as in the United States?'. Together they form a unique fingerprint.

Cite this